Basel, Switzerland

Bernhard Helk

USPTO Granted Patents = 8 

 

 

Average Co-Inventor Count = 4.6

ph-index = 3

Forward Citations = 21(Granted Patents)


Location History:

  • Basel, CH (2014 - 2019)
  • Loerrach, DE (2020)

Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: **Innovative Contributions of Bernhard Helk in Biopharmaceuticals**

Introduction

Bernhard Helk is a renowned inventor based in Basel, Switzerland, recognized for his significant contributions to the field of biopharmaceuticals. With a robust portfolio of 8 patents, Helk has developed innovative technologies that enhance the production and characterization of therapeutic proteins.

Latest Patents

Among his latest inventions is a patent for "Computer-implemented methods of determining protein viscosity." This invention provides high-throughput methods for identifying candidate antibodies based on their viscosity, an essential factor in the development of effective therapeutics. Additionally, Helk holds a patent for the "Production of glycoproteins with mammalian-like N-glycans in filamentous fungi." This technology encompasses methods for producing recombinant glycoproteins in filamentous fungal cells, ensuring that a significant percentage of the total neutral N-glycans are structured similarly to those found in mammals, enhancing the efficacy and safety of these proteins.

Career Highlights

Throughout his career, Helk has collaborated with prestigious organizations such as the Massachusetts Institute of Technology (MIT) and Novartis AG, where he has been instrumental in advancing research projects that bridge the gap between scientific innovation and practical applications in the pharmaceutical industry. His work continues to influence the field significantly.

Collaborations

Helk’s innovative journey has also been shaped by his collaboration with notable colleagues such as Bernhardt Levy Trout and Naresh Chennamsetty. These partnerships have fostered an environment of creativity and shared knowledge, leading to groundbreaking advancements in biopharmaceutical technology.

Conclusion

In summary, Bernhard Helk stands as a vital figure in the landscape of biopharmaceutical inventions. With his focus on enhancing protein production and characterization, he continues to drive innovation that holds promise for patient care and therapeutic efficacy in the pharmaceutical sector. His contributions reflect the critical intersection of technology and medicine, underscoring the importance of innovation in today's world.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…